Dieta Brandsma

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp et al. · The Lancet Oncology · 2014 · 738 citations

Neuro-oncology, Oncology, Single-agent Bevacizumab +10

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Émilie Le Rhun, Michael Weller, Dieta Brandsma et al. · Annals of Oncology · 2017 · 622 citations · Full text

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

Walter Taal, Dieta Brandsma, Hein G. de Bruin et al. · Cancer · 2008 · 458 citations · Full text

Single-cell spatial immune landscapes of primary and metastatic brain tumours

Elham Karimi, Miranda W. Yu, Sarah M. Maritan et al. · Nature · 2023 · 347 citations · Full text

Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance

Leila Akkari, Robert L. Bowman, Jeremy Tessier et al. · Science Translational Medicine · 2020 · 300 citations